mRNA |
MG-132 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.8 |
mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
phloretin |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
JQ-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.0092 |
0.8 |
mRNA |
Docetaxel |
gCSI |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
-0.0093 |
0.8 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
WP1130 |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
FQI-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.8 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0098 |
0.8 |